Drug Evaluation Department of Laboratory Testing Division, LTD of Wuxi Apptec - Nanjing Branch Opens in NJBPV

On the morning of May 24, the opening ceremony was held in Nanjing Branch of  Drug Evaluation Department of Laboratory Testing Division, LTD of Wuxi Apptec - Nanjing Branch in NJBPV, Jiangbei New Area. Chen Chanmei,deputy director of Administration Committee of Nanjing Municipal Jiangbei New Area, Nanjing, and Chen Hong, director of the life Science and Health Industry Office of Administration Committee of Jiangbei New Area, attended the opening ceremony. After the opening of Nanjing Branch of drug evaluation department of pharmaceutical testing division, it will carry out research work in various fields with radioisotope as the feature.


Wuxi Apptec is a global biomedical industry to provide comprehensive and integrated new drug R & D and production services, its service scope covers chemical research and development and production, cell and gene therapy research and development production, medical equipment testing and other fields, which has R & D centers in Shanghai, Suzhou, Nanjing and New Jersey, providing comprehensive pharmacokinetic services from early screening, preclinical development to clinical research. Its customer base covers more than 90% of the world's large pharmaceutical companies. Nanjing Branch, established in 2008, now has become a full service platform of DMPK characterized by radioisotope.


In his speech, Dr. Yang Qing, CEO of Wuxi apptec, introduced that the drug evaluation department of Wuxi Apptec Laboratory Testing Division is a comprehensive testing platform. At present, it has 800 R & D employees and more than 20000 square meters of animal facilities and laboratories in the world, and its R & D level is in a leading position in the industry. The R & D center of Nanjing Branch covers a total area of 8000 square meters. The research contents include in vitro drug absorption and distribution metabolism, in vivo pharmacokinetics, radioactive substance balance and metabolism, human absorption and metabolism excretion, safety evaluation of metabolites and other fields. At present, 80 employees have settled in the R & D center. It is estimated that by the end of 2025, the number of employees will reach 400, and the R & D capacity and scale will be further improved. Dr. Yang Qing also said that in the process of construction, Nanjing Branch has received strong support from Nanjing Jiangbei New Area and Nanjing Biotech and Pharmaceutical Valley. In the future, Wuxi Apptech will also contribute to the development of global pharmaceutical and health industry.


Chen Chanmei said in her speech that since the establishment of Nanjing Jiangbei New Area five years ago, the total GDP of the New Area has doubled, the number of high-tech enterprises has increased by six times, and the annual residential population has increased by 200,000. Among them, the number of young people aged from 18 to 34 has increased by more than 75%, and 80% of them have bachelor's degree. This series of data shows that Jiangbei new area is a hot land for development with innovation as the guide, industry as the driving force and talents as the new force. According to the 14th Five-Year Plan of Jiangbei New Area released last week, the GDP of Jiangbei New Area is planned to reach 600 billion, the output value of life and health industry is planned to reach 500 billion, and the population is planned to reach 3.5 million in the future. To focus on this goal, Jiangbei New Area has started to take many measures, in which the development of life and health industry plays an important role, and Nanjing Biotech and Pharmaceutical Valley has become an important carrier of the development of biomedical industry at the beginning of the establishment of Nanjing Jiangbei New Area. As a sunrise industry supporting the development of the new area, we have constructed a whole industrial chain and a set of perfect functional layout to promote the biomedical and pharmaceutical industry. In order to create a good ecological environment for industrial development, Jiangbei New Area has also made institutional innovations in intellectual property protection, drug risk assessment, sample import and export customs clearance, etc. Chen Chuanmei also said that Jiangbei New Area will also provide a full range of services by treating talents and their families with warmth for the talents who have settled down and will settle down in the New Area.


After the opening ceremony, the guests also visited the laboratory and office area of Nanjing Branch, and had a detailed understanding of the functional layout, R & D capacity, cutting-edge instruments and equipment.